199 related articles for article (PubMed ID: 22751694)
1. Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies.
Yi Z; Diz R; Martin AJ; Morillon YM; Kline DE; Li L; Wang B; Tisch R
Diabetes; 2012 Nov; 61(11):2871-80. PubMed ID: 22751694
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
3. Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cells.
Clark M; Kroger CJ; Ke Q; Zhang R; Statum K; Milner JJ; Martin A; Wang B; Tisch R
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34314385
[TBL] [Abstract][Full Text] [Related]
4. Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.
Vazquez-Mateo C; Collins J; Fleury M; Dooms H
BMC Immunol; 2017 Mar; 18(1):18. PubMed ID: 28356069
[TBL] [Abstract][Full Text] [Related]
5. Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.
Mehta DS; Christmas RA; Waldmann H; Rosenzweig M
Immunology; 2010 May; 130(1):103-13. PubMed ID: 20059577
[TBL] [Abstract][Full Text] [Related]
6. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
7. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
8. Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells.
Phillips JM; Harach SZ; Parish NM; Fehervari Z; Haskins K; Cooke A
J Immunol; 2000 Aug; 165(4):1949-55. PubMed ID: 10925277
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
10. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C
PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
12. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
Maki T; Ichikawa T; Blanco R; Porter J
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635
[TBL] [Abstract][Full Text] [Related]
13. Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration.
Morillon YM; Lessey-Morillon EC; Clark M; Zhang R; Wang B; Burridge K; Tisch R
J Immunol; 2016 Nov; 197(9):3504-3511. PubMed ID: 27694496
[TBL] [Abstract][Full Text] [Related]
14. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
[TBL] [Abstract][Full Text] [Related]
16. Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction.
Peng J; Dicker B; Du W; Tang F; Nguyen P; Geiger T; Wong FS; Wen L
J Autoimmun; 2007 Jun; 28(4):188-200. PubMed ID: 17412560
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
Prasad S; Neef T; Xu D; Podojil JR; Getts DR; Shea LD; Miller SD
J Autoimmun; 2018 May; 89():112-124. PubMed ID: 29258717
[TBL] [Abstract][Full Text] [Related]
18. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.
Katz JD; Ondr JK; Opoka RJ; Garcia Z; Janssen EM
J Immunol; 2010 Aug; 185(4):1999-2003. PubMed ID: 20644171
[TBL] [Abstract][Full Text] [Related]
20. Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner.
He Q; Morillon YM; Spidale NA; Kroger CJ; Liu B; Sartor RB; Wang B; Tisch R
J Immunol; 2013 Dec; 191(12):5858-66. PubMed ID: 24198282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
